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About this Report
This report by the Global hiv Prevention Working Group provides, for the first time, 
a region-by-region analysis of gaps in access to hiv prevention interventions, 
examines current spending levels versus projected need, and recommends funding and 
programmatic activities to avert 29 million of the 45 million new hiv infections 
projected between 2002 and 2010.
The Working Group’s analysis of global hiv prevention funding finds that annual spending 
from all sources in 2002 was $3.8 billion short of what will be needed by 2005. 
The report also finds that access to proven prevention interventions is extremely limited, 
and highly variable, depending on region and the intervention.
Globally, fewer than one in five people have access to
basic hiv prevention programs — the information and
services that can help save lives and reverse the aids
epidemic.* But according to a research team led by
unaids and who, two-thirds of the 45 million new hiv
infections that are projected to occur between now and
2010 could be averted, if proven prevention strategies,
used in combination, are dramatically scaled up.1
A Burgeoning Epidemic
More than 40 million people worldwide are infected with
hiv — far more than epidemiologists predicted a decade
ago — and the epidemic shows few signs of slowing. 
t In sub-Saharan Africa — where one in three adults is
living with hiv/aids in some countries — infection
rates continue to rise beyond levels previously thought
possible. 
t China and India stand on the brink of widespread
epidemics, as hiv spreads from groups at higher risk
to the broader population. 
t In the former Soviet Union, widespread injection drug
use, earlier initiation of sexual activity among young
people, and uncontrolled epidemics of sexually 
transmitted diseases are contributing to a swift
increase in hiv infection rates.
Combination Prevention Can Reverse Spread of hiv
Despite these disturbing signs, a massive expansion of
the hiv/aids epidemic is not inevitable. The reversal of
the aids epidemic can happen if proven prevention inter-
ventions are used in combination and brought to scale.
As this report documents, there is no single solution—
no magic bullet—to prevent the spread of hiv. Instead,
interventions must be used in combination to target 
the many diverse populations affected by hiv, and the
various routes of hiv transmission. Combination 
prevention uses a range of science-based strategies, from
encouraging delayed sexual activity to condom promo-
tion, from voluntary hiv counseling and testing to
programs for injecting drug users. (See box, “Achieving
Maximum Impact through Combination Prevention.”)
Coordinating Prevention, Treatment and Care
Prevention interventions will be even more potent if they
are closely coordinated with treatment, care and support
programs. Seizing the emerging opportunity to craft for
the first time an integrated response to hiv/aids will
require the rapid, coordinated and simultaneous scale-up
of prevention, care and treatment programs.‡
Opportunities to forge a comprehensive approach to
hiv/aids will likely become more numerous, as a result
of sharp declines in drug prices and increased donor
support for treatment initiatives. As experience in 
industrialized countries has shown, however, failure to
combine prevention with enhanced treatment access may
actually lead to an increase in risk behavior and thereby
make it more difficult to curb the spread of the virus. 
About the Working Group
The Global hiv Prevention Working Group — a panel 
of nearly 40 leading public health experts, clinicians,
biomedical and behavioral researchers, and people
affected by hiv/aids convened by the Bill & Melinda
Gates Foundation and the Henry J. Kaiser Family 
Foundation — seeks to inform global policy-making,
program planning, and donor decisions on hiv preven-
tion, and advocate for a comprehensive response to
hiv/aids that integrates prevention and care. In July
2002, the Working Group issued its first report, Global
Mobilization for hiv Prevention: A Blueprint for Action.2
1
* Throughout this report, global and regional access estimates derive from esti-
mates made by unaids/who in 2002.  These estimates help establish the basis
for unaids’ projections of minimum future resource needs in 2005 and 2007, as
summarized  in this report.
‡ By “scaling up,” the Working Group means achieving substantially broader
implementation of hiv prevention interventions, significantly greater and
sustained financial and human resources, and enhanced efforts to monitor and
evaluate programs and strategies. 
EXECUTIVE SUMMARY
the worst case scenario is avoidable
summary of ﬁndings
Having reviewed the most recent evidence on hiv
prevention needs and current resources, this report finds:
Access to hiv Prevention. Globally, fewer than 
one in five people at risk of infection have access 
to basic prevention services.
t Sub-Saharan Africa. In the region hit hardest by
hiv/aids, where the epidemic’s devastation is becoming
more and more acute primarily due to sexual transmis-
sion, many young people remain unaware of basic facts
about hiv/aids. Only 
six percent of people have access to voluntary 
counseling and testing and only one percent of pregnant
women are able to obtain access to 
treatment to prevent mother-to-child transmission. 
t Asia and the Pacific. In Asia, where injecting drug use is
combining with unprotected sex, rising rates of sexually
transmitted diseases (stds), and other factors that accel-
erate the spread of hiv, only 10 percent of injecting drug
users (idus) are benefiting from harm reduction
programs* and 10 percent or fewer of the most vulner-
able populations are reached by prevention interventions.
t Eastern Europe and Central Asia. The rapidly growing
epidemic in Eastern Europe and Central Asia is prima-
rily fueled by injecting drug use, and secondarily by
increasing sexual transmission. Yet only one in nine
idus in the region has meaningful access to harm
reduction programs, and only one in six people who
need std services can obtain them.
t Caribbean and Latin America. Only 11 percent of men
who have sex with men, who account for the single
largest share of infections in the region, have access to
targeted behavioral interventions, while fewer than
one-third of individuals at risk are reached by aids
awareness campaigns.
t North Africa and the Middle East. Harm reduction
programs are extremely limited in this region where
injecting drug use is a major source of transmission.
Sex workers, a highly vulnerable population in the
region, are similarly underserved; only about five
percent of sex workers and their clients have access to
targeted behavioral interventions. 
Regional Prevention Priorities. Although certain
approaches — hiv/aids awareness campaigns, voluntary
counseling and testing, and accessible std treatment —
apply to all epidemics, the global epidemic is remarkably
diverse, necessitating the tailoring of combination
prevention strategies to address national and local needs.
t Sub-Saharan Africa. Youth-targeted behavioral 
interventions, scale-up of programs to prevent mother-
to-child transmission, and supportive interventions to
address poverty and gender inequities are urgently
required in this hardest-hit region, where hiv
continues to spread rapidly. 
t Asia. The region’s multi-faceted epidemic requires
immediate scale-up of key prevention strategies —
behavioral interventions targeting especially vulnerable
populations, such as sex workers and men who have sex
with men, harm reduction programs for drug users,
programs to curb spiraling rates of stds, interventions
to address gender inequities, programs to reach out-of-
school youth, infection control in health care settings,
and implementation of blood safety procedures.
t Eastern Europe and Central Asia. The rapidly
spreading epidemic in this region is primarily driven
by injecting drug use, underscoring the imperative of
timely scale-up of harm reduction programs. Height-
ened std control and youth-targeted awareness and
behavioral interventions are also critical priorities.
t Caribbean and Latin America. Different parts of this
region will require different emphases in scaling up
hiv prevention. In the southern cone of South
2
* Harm reduction programs for idus are focused on needle and syringe programs,
substitution therapy, and outreach programs, and form part of a comprehensive
approach to drug use and hiv, which includes education about drug use, drug-free
dependence and rehabilitation, voluntary hiv counseling and testing, treatment of
sexually transmitted diseases, legal advice, and aids treatment, care and social
support for drug-dependent people living with hiv/aids.
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3America, harm reduction programs are essential to
address the growth of hiv infection among idus, while
in other parts of the region, programs targeting msm
must be dramatically scaled up. In the Caribbean,
prevention of mother-to-child transmission is a key
priority, as is the scale-up of programs to curb sexual
transmission (primarily heterosexual).
t North Africa and the Middle East. While hiv prevalence
in this region is still relatively low, there are signs that
infection rates could increase rapidly. Harm reduction
programs, as well as awareness and behavioral interven-
tions targeting sex workers, msm and other vulnerable
groups, are urgently needed to respond to growing
rates of hiv/aids.
t Industrialized Countries. Strengthened prevention
efforts are needed in wealthier countries, where 
treatment advances appear to have encouraged some
sexually active people to relax their guard against infec-
tion. In particular, prevention efforts targeting people
with hiv/aids must be scaled up and integrated into
clinical settings, programs targeting minority popula-
tions and idus must be expanded, and behavioral
programs for msm must be reinvigorated.
Funding Gap. Despite the proven efficacy of existing
prevention tools, the Working Group found that global
funding for hiv prevention efforts in low- and middle-
income countries in 2002 amounted to an estimated 
$1.9 billion — one-third of what unaids estimates will 
be needed annually by 2005 and only 29 percent of the
annual amount required in 2007. See table below.
It is important to note that the hiv prevention spending
estimates in this report are based on the best available
data. Given inadequate tracking of hiv prevention
spending from many sources, several assumptions have
been made, which are described in detail in the spending
section of this report.
In addition, the Working Group’s estimates of future
spending needs, based on analyses by unaids, must 
be understood as the bare minimum of what will be
required to mount a meaningful effort to curb the spread
of hiv. These estimates pertain solely to funds actually
needed for prevention programs at the country level and
exclude both needed funds to enhance infrastructure and
reasonable administrative expenses associated with
external assistance. 
billions (u.s. $)
0 1 2 3 4 5 6
 Worldwide* Current (2002) $1.9 billion
  Needed (2005) $5.7 billion
  Gap $3.8 billion
 Sub-Saharan Africa Current (2002)                $927 million
  Needed (2005)                         $1.5 billion 
  Gap          $573 million
 Asia and the Pacific Current (2002)        $421 million
  Needed (2005)                                $1.9 billion
  Gap                        $1.48 billion
 Eastern Europe and Central Asia Current (2002)  $23 million
  Needed (2005)                     $1.2 billion
  Gap                    $1.18 billion
 Caribbean and Latin America Current (2002)     $195 million 
  Needed (2005)                $879 million
  Gap            $684 million
 North Africa and the Middle East Current (2002)  $23 million 
  Needed (2005)    $192 million 
  Gap    $169 million
the 
funding 
gap
* Note: Regional estimates for 2002 do not equal the worldwide
total for 2002, since the worldwide figure also includes funding
for global and interregional programs.
Source: unaids; Working Group analysis
Integrating Prevention and Treatment. Scale-up of treat-
ment and care programs, itself a critical global priority,
will also help maximize the effectiveness of prevention
strategies. Coordinated, simultaneous expansion of
prevention, treatment, and care programs will permit 
the development of a comprehensive response to the
epidemic that minimizes program gaps and maximizes
prevention and treatment opportunities. 
Political Barriers. Too few national leaders, especially in
regions with emerging epidemics, have fully embraced the
fight against hiv/aids. Lack of political leadership — not
only domestically, but also among key donor nations — 
is impeding the scale-up of effective but controversial
prevention tools, such as school-based hiv prevention
interventions and needle and syringe programs.
summary of 
recommendations
Based on its analysis of the gap between current 
prevention spending and the level of resources required
to reverse the global epidemic, the Working Group makes
the following priority recommendations:
t funding: Global spending on hiv prevention activities
from all sources should increase three-fold by 2005 to
$5.7 billion, and to $6.6 billion by 2007. By 2005, high-
income nations should annually devote 0.02 percent of
gdp to hiv prevention activities — a marginal contribu-
tion of national wealth that could save millions of lives.
This level of spending is in addition to the $5.5 billion
that will be needed annually for treatment, care, and
orphan support by 2005.
t regional scale-up: Because prevention efforts
currently fall significantly short of what is needed in every
region of the developing world, prevention scale-up must
be a central priority in each region. Prevention scale-up
must also address the unique needs of each region —
from the newly emerging epidemics of Asia where hiv is
largely contained in specific high-risk groups, to the long-
established epidemics of sub-Saharan Africa, where hiv
affects the general population. Spending on hiv preven-
tion programs must increase as follows: 
• Sub-Saharan Africa: from $927 million in 2002 to at
least $1.5 billion in 2005
• Asia: from $421 million to $1.9 billion
• Caribbean and Latin America: from $195 million to
$879 million 
• Eastern Europe and Central Asia: from $23 million to
$1.2 billion
• North Africa and the Middle East: from $23 million to
$192 million
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Effective hiv prevention strategies include a combination
of complementary, science-based interventions. Just 
as combination anti-retroviral therapy attacks hiv on
multiple fronts, combination prevention uses all 
appropriate interventions to achieve maximum effect —
from delayed sexual activity to condom promotion, from
voluntary counseling and testing to programs for injecting
drug users. And just as standard hiv treatment is based
on the results of rigorous clinical research, successful 
hiv prevention uses interventions that are grounded in
scientific evidence of effectiveness. 
Interventions used in combination to prevent hiv include:
t Behavior Change Programs. In communities
throughout the world, both broad-based and targeted
interventions have dramatically changed sexual
behavior, encouraging delayed initiation of sexual
activity, mutual monogamy, and consistent and correct
condom use during sexual intercourse.3
t std Control. Because untreated stds increase the risk 
of hiv transmission by at least two to five times,4 timely
measures to prevent, diagnose and treat stds represent 
an essential component of effective hiv prevention.5
t Voluntary Counseling and Testing (vct). Knowledge of
infection typically leads individuals to avoid exposing
others to the virus. A study involving more than 4,000
people in Kenya, Tanzania, and Trinidad found that vct
was more effective in reducing reported risk behaviors
than simple provision of health information.6
t Harm Reduction Programs for Injecting Drug Users.
Needle and syringe programs can help prevent major
achieving maximum impact through 
combination prevention
5t high-impact interventions: In the immediate
future, prevention efforts should aggressively focus on
bringing to scale especially cost-effective, high-impact
interventions. Scale-up is urgently required for programs
delivering vct, harm reduction interventions, std control,
and prevention of mother-to-child transmission. And
nearly $200 million in additional funding is needed each
year to ensure an adequate global supply of condoms.
t prevention and treatment: As both prevention and
treatment programs are brought to scale, these initiatives
should be carefully integrated to create a single
continuum of services. Health care workers should be
trained to provide hiv prevention counseling, and referral
and linkage mechanisms must be created to ensure swift
transition from a positive test result to health care access.
t building capacity: In addition to funding for preven-
tion interventions themselves, donors should, in collabo-
ration with multilateral agencies, provide extensive
additional support to build long-term human capacity
and infrastructure. Targeted research and other initiatives
should immediately be undertaken to clarify the level of
resources required to build sufficient infrastructure to
support a long-term prevention effort in low- and middle-
income countries.
t development assistance: Development assistance and
policy reforms should address the social and economic
conditions that increase vulnerability to, and facilitate the
rapid spread of, hiv/aids. Through expanded debt relief,
microfinance initiatives, more equitable global trade rules,
and international efforts to prevent or ameliorate civil
conflict, donor countries and multilateral institutions
should recognize that the response to hiv/aids plays a
central role in the broader development agenda. All such
development efforts must be designed to reduce gender
inequities and enhance economic and political opportuni-
ties for women and girls. 
t prevention research: Research into new prevention
strategies and technologies should be strengthened and
accelerated. To accelerate the search for a safe and effective
vaccine and microbicide, funding for each of these areas 
of research should increase by $1 billion. Leading research
agencies and multilateral institutions should meet regu-
larly to identify gaps in prevention science research and
develop collaborative plans for needed research. As new
prevention strategies emerge, they should be rapidly 
integrated into national prevention efforts.
t resource tracking: All donors should focus on
improving data collection regarding the magnitude and
nature of hiv/aids spending in low- and middle-income
countries. Bilateral donors, multilateral donors, ngos and
foundations should report annually to a single data
collection mechanism to track and report on the flow of
hiv/aids resources in developing countries.
outbreaks of hiv/aids among drug users.7 Programs to
prevent and treat substance addiction, as well as peer
outreach, also play an important role in preventing the
spread of infection.8
t Prevention of Mother-to-Child Transmission (pmtct).
A package of interventions — including vct, timely
administration of antiretroviral therapy to mother and
newborn, and counseling regarding breastfeeding 
alternatives — reduces by 50 percent or more the risk 
of hiv transmission from mother to child.9
t Blood Safety. By implementing measures to improve
the safety of the blood supply, it is possible to nearly
eliminate the risk of hiv transmission from blood 
transfusions.10 Recommended policies include creation
of a national blood service, use of low-risk donors,
routine screening of blood donations, and reduction 
of unnecessary transfusions.11
t Infection Control in Health Care Settings. Adherence to
universal precautions and use of safer technologies can 
significantly reduce the risk of exposure to hiv in health
care settings.12
t Structural Interventions. Policy reforms — such as
universal primary and secondary education, legalization
of the sale of syringes without a prescription, and
mandating the use of condoms in brothels — help
reduce the risk of transmission by altering the environ-
ment in ways that promote risk reduction.13 Reforms
are also needed to reduce inequities experienced by
women and young girls and to increase their economic,
political and social power.
t Programs for People Living with hiv. A weakness in
prevention strategies in many countries has been the
failure to target intensive prevention efforts to people
who have been diagnosed with hiv. A comprehensive
prevention strategy must include programs to assist
people living with hiv/aids to take measures to avoid
the possibility of exposing others to infection.
hat drives the epidemic — and how combination prevention should be tailored to achieve maximum
impact — differs between and within regions. Using data compiled by unaids and who, the Global hiv
Prevention Working Group has analyzed existing access to prevention and the prevention resource gap in
each region of the developing world.
This section provides regional profiles that:
t Summarize the status of the epidemic in the region
t Identify key prevention access gaps
t Quantify the gap between resource needs and current spending in the region on hiv prevention
t Highlight prevention successes on which future strategies should build
6
THE HIV
PREVENTION
ACCESS GAP
A REGION-BY-REGION 
SURVEY
the global hiv prevention access gap
Today, fewer than one in five people at risk of infection have access to basic hiv prevention services.14 To identify
specific access gaps, who and unaids convened a panel of experts in 2002 to estimate the percentage of people at
risk of hiv infection in low- and middle-income countries who had access to prevention services in 2001. The
results, primarily derived from UN surveys, demonstrate that basic prevention interventions remain out of reach 
for most people at risk.15*
t Prevention of mother-to-child hiv transmission: Among pregnant women visiting antenatal clinics, only 
five percent have access to services to reduce the risk of mother-to-child transmission.
t Voluntary hiv counseling and testing: Only 12 percent of people who want to be tested for hiv are able to 
access voluntary counseling and testing services.
t Harm reduction for injecting drug users: Only 19 percent of injecting drug users have access to harm reduction
programs.
t aids education/behavior change programs: Fewer than one in four people at high risk have meaningful access
to hiv/aids information necessary to reduce the risk of infection.
t Condoms: More than 20 years into the hiv/aids epidemic, fewer than half (42 percent) of all people at risk of
sexual exposure to hiv are able to obtain a condom. 
* Although coverage of all prevention interventions must dramatically increase to influence the course of the epidemic, it is not essential to achieve 100 percent
coverage for every existing prevention tool in every low- and middle-income country.  Where hiv prevalence is high — either in a geographic area, such as sub-
Saharan Africa or parts of the Caribbean, or in a particular population, such as injecting drug users in the Russian Federation or urban sex workers in certain Asian
countries — maximum coverage will be needed in order to slow the epidemic.  For high-prevalence countries, unaids and who have established 100 percent
coverage targets by 2007 for mass media campaigns, basic hiv education, prevention and treatment of sexually transmitted diseases, voluntary counseling and
testing, blood safety measures, safe injection practices, and post-exposure prophylaxis for health care workers; 70 percent coverage; (50 percent by 2005) for
programs to prevent mother-to-child transmission; 60 percent coverage targets for condom use during risky sex; and 50 percent coverage targets for workplace
prevention programs and prevention interventions for out-of-school youth.
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status of the epidemic in sub-saharan africa
t hiv Prevalence. Approximately 29 million people — including 10 million young people (ages 15–24) and three
million children under age 15 — are currently living with hiv/aids in sub-Saharan Africa. According to unaids, 
one in every 11 adults in the region — one in three in some countries — is infected with hiv.16
t Rate of Growth. In 2002 alone, 3.5 million people in the region contracted hiv, accounting for 70 percent of the
world’s new infections.17
t Epidemic History. The epidemic in the southern and eastern parts of the region is now generalized, touching 
virtually every segment of society. Contrary to previous projections, infection levels in many of these countries
continue to mount.18 In west and central Africa, where epidemics are less severe, the rate of new infections appears
sub-saharan africa
population 633,816,000
hiv prevalence 8.8% 
high botswana, 38.8%
main mode of transmission heterosexual
t Harnessing the Workplace. Studies
have documented the strong potential
to promote effective hiv prevention in
work settings. In Zimbabwe, for example, 
factories where peer-based hiv/aids education
programs were implemented had a 34 percent lower
rate of new infections than comparable workplaces
with no such programs.42 Other countries are also
focusing on the workplace as an essential venue for 
effective hiv prevention programs. The government of 
Côte d’Ivoire, for example, has called on all businesses with
more than 50 employees to establish hiv/aids committees,
while the government of Cameroon envisions by 2005
having agreements with 50 percent of all business requiring
hiv/aids education for workers. In South Africa, periodic
presumptive std treatment for mineworkers has
reduced stds among workers and among sex
workers from the community.
t Increasing Access to Condoms. As part of the
government’s efforts to scale up hiv prevention,
public sector distribution of condoms in South
Africa increased from six million in 1994 to 358
million in 2002. An increasing number of countries are
seeking to scale up condom distribution and promotion
programs, and are tracking usage patterns once condoms
are distributed. Researchers in South Africa surveyed nearly
400 individuals who received more than 5,500 condoms
through public sector distribution. After five weeks, nearly
44 percent of the condoms had been used during sex,
likely to increase significantly. In eight countries in
west and central Africa, adult hiv prevalence has now
surpassed five percent.19 Between four and six million
people are estimated to be infected in Nigeria, Africa’s
most populous country, and the U.S. National Intelli-
gence Council projects that up to 15 million people
(more than one quarter of the adult population) will 
be infected by 2010. The Council also projects that
infection rates in Ethiopia will escalate from official
estimates of 2.7 million infections in 2002 to up to 
10 million by the decade’s end.20
t Primary Modes of Transmission. The majority of hiv
transmission in the region stems from sexual behavior
(largely heterosexual).21 Sub-Saharan Africa is also
home to roughly 90 percent of the 800,000 infants
who contract hiv each year before or during birth or as
a result of breastfeeding, although this percentage is
slowly declining as epidemics grow in other regions.22
An estimated 2.5% of new infections in Africa stem
from unsafe injection practices.23
t Key Populations for Prevention Programs
Women. In sub-Saharan Africa, women account for 58
percent of all hiv infections, and infection rates among
young women ages 15–24 are approximately twice as
high as those among young men.24 The growing
disparity between male and female infection rates in
Africa reflects the degree to which gender inequities
are now driving the epidemic in sub-Saharan Africa, as
women who lack economic independence, educational
opportunities, and access to health information and
services often have difficulty avoiding exposure to 
the virus. Gender-focused prevention programs must
address the many economic, social and political disad-
vantages that directly increase women’s vulnerability to
hiv infection.25
Young People. More than 40 percent of people living
with hiv/aids in sub-Saharan Africa are between the
ages of 15 and 24,26 and young people account for more
than half of all new infections in the region.27 Surveys
indicate that, on average, young people in the region
begin having sex at an early age (average age of initia-
tion is 13 for boys, 14 for girls) and generally do not use
condoms.28 Especially vulnerable are the more than 11
million young people in the region who have already
been orphaned by hiv/aids.29
Sex Workers. Desperate economic circumstances force
many women to engage in survival sex in sub-Saharan
Africa, placing them at high risk of contracting hiv
and transmitting the virus to their sex partners.
Studies of sex workers at truck stops in South Africa 
in 1996–1999 found hiv prevalence higher than 50
percent and annual hiv incidence of 20 percent.30
Migrant Populations. Numerous studies have detected
high infection rates among truck drivers and seasonal
migrant workers in the region.31 In addition, 
sub-Saharan Africa faces numerous wars and civil
conflicts, producing large numbers of refugees who
also face a heightened risk of contracting hiv.32
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prevention successes in africa
gaps in access to 
hiv prevention in
sub-saharan africa
Targeted Behavioral Interventions. Although Uganda,
Senegal, Zambia and other African countries have made
enormous strides against the epidemic by supporting
interventions targeting key populations, many people at
highest risk for infection cannot obtain the support they
need to change their behaviors to avoid exposure to hiv.
t Behavioral intervention gap: Only 8% of out-of-school
youth and a little more than one third of in-school youth
have access to prevention programs. Fewer than one in
12 sex workers and their clients are currently targeted
by behavioral programs. 
Condom Promotion and Access. Current donor contribu-
tions are sufficient to provide roughly three condoms 
per year for every adult male in sub-Saharan Africa — 
a major shortcoming in this hardest-hit region where 
the epidemic is largely driven by heterosexual sex.33
An additional 1.9 billion condoms would be needed to
raise all countries to the average procurement level of the
six African countries that use the most condoms.34
t Condom gap: 1.9 billion additional condoms needed
annually
t Condom promotion gap: Fewer than one in three people
at risk have access to condom social marketing or other
programs that provide condoms. 
Prevention of Mother-to-Child Transmission. As sub-
Saharan Africa accounts for roughly 90 percent of the
800,000 infants who acquire hiv each year, pmtct
programs represent a central prevention priority in the
region. Currently, however, it is estimated that 99
percent of women who need pmtct in the region do 
not have access to these services.35
t pmtct gap: Only 1% of women in need have access. 
Diagnosis and Treatment of Sexually Transmitted
Diseases. Many countries in sub-Saharan Africa have a
high prevalence of stds, accelerating the spread of hiv.
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roughly 22 percent had been given away, and 26 percent
were still available for use. Fewer than 10 percent of the
condoms distributed by the government program had been
lost or discarded.43
t Taking Youth-Oriented Prevention to Scale in South
Africa. Although research has identified a broad range of
prevention projects that appear to produce significant
behavior change, few such projects have been brought to
scale. In South Africa — where the future course of the
epidemic will largely be determined by the sexual behaviors
of the 40 percent of South Africans under age 15 — a
central challenge is to convert smaller-scale prevention 
projects into broad-based programs capable of reaching
millions. loveLife — a partnership between the South
African government, more than 100 community-based
organizations, U.S. foundations, and the corporate 
sector — is scaling up on a nationwide basis a comprehen-
sive package of proven prevention approaches, with the
goals of reducing by one-third the number of young people
who engage in high-risk sex and of encouraging a substan-
tial percentage of young people to delay initiation of sexual
activity. Components of the program include youth-focused
multimedia programming of unprecedented scope and
intensity, as well as development of youth-friendly services
in government clinics countrywide and a network of youth
centers and health care delivery sites. A comprehensive
evaluation of the program is underway to determine its
impact on young people’s sexual behaviors and on the 
incidence of hiv and stds.
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In rural South Africa, nearly nine percent of adults 
have syphilis and almost one in 20 has gonorrhea.37
In Swaziland, for example, more than one-half of
patients attending std clinics tested hiv-positive in
2000,38 while seropositivity among std clinic patients 
in Zimbabwe exceeded 70 percent in 1995–96.39
t std treatment gap: only 14% of people in need of std
services can obtain them. 
Voluntary Counseling and Testing. Today, only six percent
of people who want hiv counseling and testing in Africa
have access to it.40 With an estimated 29 million people
currently living with hiv/aids, it is likely that the vast
majority are unaware they are infected.
vct gap: only 6% of people who want vct have access to it. 
Infection Control and Safe Injection Practices in Health
Care Settings. Use of unsterile injection equipment
during mass vaccination campaigns or in other health
care settings is believed to be responsible for more than
80,000 infections annually in sub-Saharan Africa,40
underscoring the urgent need for rapid scale-up of infec-
tion control and safe injection practices in the region. 
t Gap in health care settings: Only 18% of health care
settings adhere to universal precautions, and only 20%
of medical injections are safe. 
Broad-Based hiv/aids Awareness. Notwithstanding the
devastation already caused by hiv/aids, key population
segments in some African countries do not possess basic
information that could save their lives. unicef reports
that more than one-half of all young people (ages 15–24)
in more than a dozen countries (primarily African) have
never heard of aids or have serious misconceptions
about how hiv is transmitted.41
t Awareness gap: Only 43% of people at risk are reached
by mass media awareness programs. 
Supportive Initiatives. Although available interventions and
technologies are highly effective in reducing transmission
rates, prevention strategies will be optimally successful 
if they address the social and economic conditions that
accentuate vulnerability to hiv. Limited educational oppor-
tunities for girls, for example, are directly correlated with
higher teen pregnancy rates and earlier initiation of sexual
activity. Where a woman’s economic security depends on a
man, she may be less able to negotiate condom use during
sex. From a societal standpoint, countries that are too poor
to support even a minimal health care infrastructure are
unlikely to have the wherewithal to provide vct, std
diagnosis and treatment, or pmtct.
hiv prevention
resource gap in 
sub-saharan africa
t Current Prevention Resources. Extrapolating from 
estimates by unaids, the Working Group estimates
that spending in 2002 on hiv prevention services from
all sources — including donor countries, domestic
governments, and affected households — amounted 
to approximately $927 million.* 
t Estimated Need. unaids estimates that $1.5 billion
annually will be needed by 2005 — and $1.65 billion
by 2007 — to bring combination prevention programs
to scale in the region.
t Prevention Resource Gap: $573 million additional
annual spending needed by 2005
* In the absence of reliable data on prevention spending in different regions, the
Working Group has derived regional estimates by applying the global prevention
share (54 percent) of all global hiv/aids spending in 2002 to each region’s overall
hiv/aids spending.
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One of the poorest countries in the world,
Uganda confronted one of the most severe
early hiv/aids epidemics in the mid-1980s.
In Kampala, the nation’s major urban area, 11
percent of women attending prenatal clinics
were already infected by 1985.44
In 1986, President Yoweri Museveni became the first
African leader to speak openly about hiv/aids. That
same year, Uganda established its National aids Control
Program, which launched an aggressive aids awareness
campaign and began to enlist key national stakeholders,
such as community leaders, civil society, and faith-based
groups, in the fight against the disease. Treatment for
sexually transmitted diseases was expanded, and Uganda
became the first African country to provide voluntary hiv
counseling and testing services.45 As a result, overall
prevalence in Uganda has declined from 15 percent in
1991 to five percent in 2001.46
A key finding from Uganda’s experience is that no single
factor or intervention can adequately explain the country’s
extraordinary progress in reversing its potentially cata-
strophic epidemic. Uganda’s success underscores the
effectiveness of a combination of proven approaches to
hiv prevention: aids awareness campaigns, community
mobilization, targeted behavior change programs—
encouraging delayed initiation of sex, mutual monogamy,
and condom use—voluntary counseling and testing, and
treatment of stds. 
As a result of these efforts, Uganda has
made unparalleled progress in reversing its
epidemic. While 50 percent of 15-year-old
girls in Uganda were sexually active in 1989,
fewer than 25 percent had initiated sexual
activity by the same age in 1995.47 In compar-
ison with their counterparts in Kenya,
Zambia, and Malawi, young males (15–19) in
Uganda were significantly more likely in 1995 to have
never had sex, to be married and monogamous, and to
have fewer sexual partners. While only 16 percent of males
in Uganda reported ever using condoms in 1995, 40
percent reported condom use in 2000.48
The impact of these behavior changes on infection rates
has been substantial. In every prenatal setting in the
country where hiv is tracked, the level of infection has
declined significantly since 1992 — from nearly 30 percent
to 11.25 percent in Kampala, and from 13 percent to 5.9
percent in clinics outside major urban areas.49 A compre-
hensive study of 15 neighboring communities in the
Masaka district in rural southwest Uganda found that the
rate of new infections in 1995–99 was 37 percent lower
than in 1990–94.50
11
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The hiv risk faced by women and girls is growing, as
gender inequities become an increasingly prominent
driving force in the epidemic. Globally, as many women
are living with hiv/aids as men. In Africa, women now
account for 58 percent of hiv/aids cases, and this
proportion is steadily rising. 51 In Asia, gender inequities
play a major role in the epidemic, and infection rates
among women will continue to rise.
Among the factors contributing to a heightened risk of
transmission among women and girls are:
t Limited Access to Prevention Options and Health
Services. Use of the male condom, the primary means
of preventing hiv transmission among sexually active
people, is not under women’s control. Moreover,
many women and girls lack effective access to health
information or reproductive health and family 
planning services. 
t Legal Disenfranchisement. In many countries heavily
affected by hiv/aids, laws restrict the right of women
to own or inherit property.52 These laws perpetuate
women’s economic dependence on men, which in
turn limits the independence and autonomy they need
to refuse sex or negotiate condom use. unaids
reports that 80 percent of hiv-positive women
acquired the virus from their partners in stable, 
long-term relationships. 
t Diminished Educational Opportunities. Especially in
sub-Saharan Africa, many girls in families affected 
by hiv/aids are forced to drop out of school to care
for family members or to work to make up for lost
income. Due to limited schooling, these girls will be
more dependent on men as they grow older. 
t Sexual Violence. In many countries, sexual violence
against women and girls is both common and a major
source of hiv transmission.53
t Sexual Trafficking. Many young people, especially
girls, are coerced — either physically or by economic
circumstances — to enter sex work.
t Inter-Generational Sex. Young women, who are 
physiologically more susceptible to hiv than young
men, most commonly have their first sexual experi-
ences with older men. In countries where adult hiv
prevalence is high and condom use low, this results
in substantial hiv transmission. In Kenya, while 
hiv prevalence among young men ages 15–19 was 
3.4 percent, 23 percent of young girls ages 15–19 
were infected.54
Although these and other factors are deeply ingrained 
in many societies, experience has shown it is possible 
to prevent hiv transmission by empowering women.55
To diminish the vulnerability of young people from
sexual trafficking, for example, Thailand in 1992 initiated
a comprehensive program to reduce the willingness 
of families to direct young girls toward sex work. In 
addition to the implementation of legal measures to
suppress sexual trafficking, Thai officials worked 
effectively with families and with society at large to 
alter attitudes toward child prostitution.56
By coupling prevention programs with energetic political
and social reforms, efforts to curb the spread of hiv
among women and girls can be even more effective. 
ﬁghting aids by empowering
women and girls
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status of the epidemic in asia and the paciﬁc
t hiv Prevalence. Although overall infection rates are relatively low in the region (under one percent prevalence), 
the actual number of people infected is already substantial — 7.2 million. Adult hiv prevalence is highest in
Myanmar (3.5 percent),57 followed by Cambodia (2.7 percent), Thailand (1.8 percent), India (0.8 percent), and 
Papua New Guinea (0.7 percent).58
t Rate of Growth. The epidemic is rapidly expanding in Asia, with nearly one million people becoming infected in
2002,59 compared to 700,000 in 2000.60
t Epidemic History. The epidemic in the region includes countries such as Thailand, where hiv began to spread widely
in the early 1980s, as well as China and India, where the epidemic initially began in the late 1980s. Asia currently
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presents the greatest risk of expansion of the global
epidemic. While the region currently accounts for 20
percent of current infections, experts project it will
contribute 40 percent of all new infections by 2010, 
in the absence of a vigorous prevention response.61
In 2003, countries of major concern include:
China. The Chinese government projects that, in the
absence of major new prevention efforts, the country will
have 10 million hiv infections by 2010 — an estimated
10-fold increase over current levels.61 In March 2003, 
the Chinese state media reported that hiv infection in
the country would increase by 30 percent in 2003.63
India. U.S. intelligence experts believe hiv/aids is
poised to escalate in India, a scenario that could
generate up to 20 to 25 million new infections between
2002 and 2010, from 4 million today. 
Indonesia. A country that until 1998 had hiv preva-
lence rates below 0.1 percent, even in key populations
at highest risk, Indonesia is now experiencing a rapid
spread of infection. Seroprevalence among idus
attending a drug treatment center in Jakarta climbed
from zero in 1998 to nearly 50 percent in 2001. 
Infection rates among sex workers in some parts of the
country now approach five percent and are increasing. 
t Primary Modes of Transmission. Injection drug use
and heterosexual intercourse are the primary modes 
of transmission in the region, although substantial
transmission also occurs as a result of sexual contact
between men.64 Improper blood collection practices
have also caused hundreds of thousands — and some
estimate that it may be millions — of infections in
China.65 In India and surrounding countries, nearly
one in four new infections stems from unsafe injection
practices in health care settings.66
t Key Populations for Prevention Programs
Women. Although India’s hiv/aids epidemic was
initially driven primarily by transmission among male
idus, infection is rapidly spreading to their female sex
partners. In seven Indian states, hiv prevalence among
women attending prenatal clinics now exceeds one
percent.67 Gender inequities significantly increase
women’s vulnerability to hiv/aids; in some parts 
of Asia, young girls are frequently steered by their
families toward sex work. 
Sex Workers. More than 30 percent of sex workers 
in some parts of India are infected with hiv,68 and
sentinel surveillance has detected infection rates
higher than 60 percent in some sex worker popula-
tions in Cambodia.69 In Asia, as in other parts of the
world, sex workers are not only highly vulnerable
themselves, but their clients often serve as a key
epidemiologic bridge to the broader population. 
Men Who Have Sex with Men. msm communities in
Asian countries have very high rates of infection — 14
percent in Cambodia,70 20 percent in India,71 and 15
percent in Thailand.72 Although reliable estimates are
not available for China, government officials believe
that msm networks are an important contributor to 
hiv transmission in the country.73 Not only are msm
a highly vulnerable population requiring heightened
prevention attention, but there is also evidence that
they serve as an important epidemiologic bridge to
women in Asia, as one study of msm in Cambodia
found that 40 percent had sex with both men and
women in the prior month.74
Young People. In Asia, as in other regions, the rapid
spread of hiv places young people at particular risk.
According to unaids, recent evidence suggests that
rates of unsafe sexual behavior among Thai youth 
may be increasing.75
Migrant Populations. Population mobility increases
risk-taking behaviors by disrupting social support
networks, contributing to depression and other mental
health problems, and frequently placing individuals in
risky circumstances that facilitate unsafe behavior. An
estimated 100 million people in China have migrated
in recent years from rural areas to the cities in search
of work.76 unaids reports that in the Phillipines more
than one quarter of all people living with hiv/aids
have worked in other countries.77
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Targeted Behavioral Interventions. Fewer than one in 
10 people belonging to especially vulnerable groups
currently have access to behavior change programs.
t Behavioral intervention gap: Behavior change programs
reach only 5% of sex workers and their clients, 3% of
out-of-school youth, and 10% of msm.
Condom Promotion and Access. Although at least $135
million worth of condoms should be purchased annaully
to address hiv/aids in Asia, donors bought only $17.5
million worth of condoms in 2000.78 While India, China
and other countries purchase and distribute condoms on
their own, the gap between condom supply and actual
need remains substantial. 
t Condom gap: Only 24% of people who need condoms
in South and Southeast Asia — and only 28% in East
Asia and the Pacific — have access to programs that
provide condoms and promote their use. 
Prevention Programs for Injecting Drug Users. Cheap and
easily available heroin has combined with rapid social
change and dislocation in much of the region to produce
a dramatic rise in the number of idus. The government
of China, for example, reports that the number of idus
in that country rose from 70,000 in 1990 to more than
900,000 in 2001.79 According to unaids, more than 
half of idus are already infected in parts of Malaysia,
Myanmar, Nepal, Thailand, and Manipur in India,80
yet only a small fraction of idus in the region currently
has access to harm reduction programs. 
t idu prevention gap: Only 10% of idus have access to
harm reduction programs.
Diagnosis and Treatment of Sexually Transmitted
Diseases. As in other countries undergoing rapid social
and economic transition, China has seen std rates rise as
its economic system has been liberalized and its public
health system decentralized. Between 1986 and 2000,
the number of reported stds in China increased from
fewer than 24,000 to nearly 860,000.81
t std treatment gap: Only one in seven people who need
std services in Asia has access to such programs. 
Prevention of Mother-to-Child Transmission. In Thailand,
mother-to-child transmission accounts for 4.6 percent of
all reported aids cases,82 while sentinel surveillance in
Cambodia detects infection rates higher than three percent
among pregnant women in urban areas.83 In India,
170,000 children are living with hiv/aids.84 These numbers
are likely to grow unless immediate efforts are undertaken
to follow Thailand’s lead in scaling up pmtct services. 
t pmtct gap: Only 3-6% of women have access to pmtct
services.
Voluntary Counseling and Testing. Access to vct is highly
variable in the region. An estimated 69 percent of people
in South and Southeast Asia who want to learn their
serostatus have access to vct. In China, by contrast, where
one million or more people are infected with hiv, who
reports that only 25,000 individuals received vct in 2001.85
t vct gap: Although 69% of people in South and South-
east Asia who want vct can obtain it, only 6% of people
in East Asia and the Pacific have access.
Infection Control in Health Care Settings. hiv transmis-
sion through contaminated injections is most common
in Asia, where more than 160,000 contracted the virus
in this manner in 2000.86
t Health care settings gap: Only 20% of people in the
region have access to safe medical injections, and fewer
than one-fifth of health care settings adhere to universal
precautions. 
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Broad-Based hiv/aids Awareness. Basic educational and
awareness programs are urgently needed to fill a poten-
tially deadly information gap in the region. More than
half of all young people (ages 15–24) in Vietnam have
either never heard of aids or do not accurately under-
stand how hiv is transmitted.87
t Awareness gap: Only 22% of people at risk in South 
and Southeast Asia, and only 19% in East Asia and the
Pacific, are currently reached by mass media awareness
campaigns. 
Supportive Initiatives. hiv/aids remains highly 
stigmatized in many Asian countries, helping maintain 
a silence that impedes effective hiv prevention efforts.
Prevention efforts in the region will be optimally effective
only if they are accompanied by sustained efforts to
relieve the stigma of hiv infection and eradicate hiv-
related discrimination. 
hiv prevention
resource gap in 
asia and the paciﬁc
t Current Prevention Resources. The world’s success in
turning the tide against hiv/aids will be determined 
in great part by whether the epidemic can be curbed in
Asia. Not only is the region the world’s most populous,
but alarming increases in infection rates in India, China
and Indonesia raise the prospect of a major expansion of
the epidemic. The Working Group estimates that 2002
funding for hiv prevention programs in Asia from all
sources was less than $421 million. 
t Estimated Need. International donors and Asian 
countries themselves have, in large measure, been slow
in providing critical financial support for prevention
measures. By 2005, Asia will need approximately $1.9
billion annually to mount a comprehensive hiv preven-
tion effort — a sum that will grow to more than $2.4
billion by 2007. To prevent a major expansion of the
epidemic into the general population of key Asian 
countries, a nearly six-fold increase in hiv prevention
spending is needed over the next two years.
t Prevention Resource Gap: $1.48 billion additional
annual spending needed by 2005
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t Changing Social Norms in Thailand. aids experts
have long been familiar with the success
achieved by Thailand’s “100% condom”
program, which mandated use of condoms in
brothels. Less well-known is the success of the
country’s efforts to alter long-established norms
regarding male patronage of commercial sex businesses.
Between 1990 and 1993, the percentage of men (ages 15–49)
who visited brothels during the prior 12 months fell from 19
percent to 9 percent, with an especially notable decline (35
percent to 17 percent) among young men (20–24). 
t Broad-Based Prevention in Cambodia. Faced with a
rapidly expanding hiv epidemic in the mid-1990s,
Cambodia adopted and began scaling up a multisectoral
hiv/aids strategy, with important results. Between 1995
and 1999, hiv prevalence among brothel-based sex
workers declined from 40 percent to 33 percent, and sex
workers and their clients significantly increased condom
use.88 Between 1997 and 2000, hiv prevalence among
pregnant women declined by almost one-third.89
t Empowering Sex Workers in
India and Bangladesh. The innovative
Sonagachi sex worker project in India
develops linkages with key participants in the
sex industry — including brothel owners
and the police — to reduce prejudice
against sex workers and promote
effective care initiatives for their
families and children. Designed and implemented by sex
workers themselves, the Sonagachi project has been
expanded to reach more than 30,000 workers in 30 red light
districts in the state of West Bengal. The model has also
been replicated in Bangladesh.90
t Scaling Up std Control in India. Periodic “pulse
campaigns” target rural populations for std diagnosis and
treatment services in all administrative districts in India.
As a result of these efforts, more than 70 million people
attended health camps sponsored by the project in 2001,
and three million people were treated for stds.91
prevention successes in asia and the paciﬁc
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The male condom remains an essential component of a
comprehensive strategy to reverse the global hiv/aids
epidemic, but too few people at risk have access. 
t Condom Access Gap
According to unaids, the 6 to 9 billion condoms that are
distributed each year constitute as little as one quarter of
what is needed to reach those in need.92 The supply of
condoms in Africa, for example, averages roughly three
condoms per year for each adult male.93
t Condom Promotion
Condoms help curb the spread of hiv only if they 
are used. Efforts to increase the public provision of
condoms must be supported by behavior change
communication for safer sex. As this report reveals,
every region suffers from acute shortages of programs 
to promote condom usage. 
t Condom Resource Gap
Such shortfalls directly stem from insufficient global
financing for procurement and promotion of this essen-
tial prevention commodity. Although the United Nations
Population Fund estimates that annual spending on
condom purchases should equal $239 million to satisfy
the global need for the prevention of hiv and stds, 
international donors spent only $45.9 million in 2000 —
roughly 19 percent of what is needed.94
t Condom Effectiveness
Controlled scientific studies have demonstrated that
condoms are up to 98 percent effective in preventing
hiv transmission when used consistently and correctly.95
Condoms were also affirmed to be highly effective in
preventing hiv in an interagency review undertaken in
2001 by the U.S. Public Health Service.96 Several U.S.
studies of correct and consistent condom use show 
that latex condom breakage rates are less that 2
percent.97 Although poor-quality condoms can break 
or tear, the vast majority of condoms distributed in 
low- and middle-income countries adhere to rigorous
manufacturing standards. 
Countries both rich and poor have effectively
promoted condoms as a critical hiv prevention strategy.
Thailand’s condom promotion efforts, for example,
played an important role in the country’s success in
reducing hiv infection rates by more than 80 percent.
Similarly, sharp declines in the 1980s in hiv incidence
among gay and bisexual men in the U.S., Europe, and
Australia were directly tied to increased condom use.
t Female Condoms
Because many women at risk for hiv infection have 
difficulty negotiating condom use with their male part-
ners, greater access to female-controlled prevention
methods is an urgent global health need. Following
studies indicating acceptability of female condoms
among women and their sex partners,98 distribution and
use of such products has increased, although availability
of female condoms remains substantially short of need. 
the condom gap
ensuring access to an essential
tool in the ﬁght against hiv/aids
status of the epidemic in eastern europe
and central asia
t hiv Prevalence. An estimated 1.2 million people are currently living with hiv/aids in Eastern Europe and Central
Asia, reflecting region-wide prevalence of 0.6 percent among adults (15–49).99 U.S. intelligence experts believe 
the actual number of infections in the region may be substantially higher than official estimates — perhaps one 
to two million in Russia alone.100
t Rate of Growth. The epidemic is spreading fastest in Eastern Europe and Central Asia, with an annual rate of 
increase above 25 percent. In 2002 alone, 250,000 people in the region became infected with hiv.101 Without 
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implementation of 
effective prevention 
measures, intelligence experts
project that adult hiv prevalence 
in Russia will surge from one to two
percent currently to between six and 11
percent by 2010, generating as many as eight
million hiv infections during that time.102
t Epidemic History. The epidemic is relatively new in
the region, dating to the early 1990s.103
t Primary Modes of Transmission. Injection drug use —
abetted by the cheapness of heroin, the existence in 
the region of major drug trafficking networks, and
social dislocation caused by rapid economic and 
political change — drives the epidemic in the region,
accounting for 90 percent of reported cases in
Russia.104
t Key Populations for Prevention Programs
Injection Drug Users. Injection drug users, now the
driving force in the region’s emerging hiv epidemic,
require sustained behavioral interventions to encourage
them to adopt safer injecting behavior, reduce or 
eliminate drug use, and use condoms during sexual
intercourse. 
Young People. In addition to the risk of transmission
through increasingly prevalent drug-using practices,
young people in the region face the growing risk of
sexual acquisition of hiv. Accompanying the rapid
social and economic changes in the region has been a
marked change in sexual behaviors. unaids reports
that young people in the former Soviet Union are now
having sex at an earlier age and that social strictures
against premarital sex are easing. Youth-appropriate
prevention programs, coupled with investment in basic
sex education, are needed to prevent an escalation in
sexual transmission among the region’s young people.
Men Who Have Sex with Men. Although only limited
data exist on hiv prevalence among msm in the region,
studies indicate that most msm do not typically use
condoms and many engage in sex work.105
Sex Workers. Seroprevalence among some urban sex
worker populations in Russia exceeds 15 percent,
according to studies in 1999 and 2000.106 In Eastern
Europe, as in many other regions, many sex workers
also inject drugs. 
Sex Partners of idus. According to the U.S. National
Intelligence Council, idus are often well integrated
into Russian society. Without swift scale-up of preven-
tion services for the sex partners of idus, hiv/aids
could rapidly spread to the population at large.
Correctional inmates. An estimated 20 to 25 percent of
correctional inmates in Russia are infected with hiv,
and infections have also been reported in correctional
populations in other countries in the region.107 Periodic
amnesty programs and the normal release of prison
inmates mean that the correctional population, in addi-
tion to being highly vulnerable itself, also functions as a
potentially significant bridge to the broader population. 
gaps in access to 
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Prevention Programs for Injecting Drug Users. An esti-
mated one percent of the adult (15–49) population in
Russia inject drugs regularly, with estimates as high as
three percent in some urban areas.108 Among young
people, the rates may be even higher.109 Drug use is a
source of great stigma in the region, encouraging govern-
ments to address hiv transmission among idus from a
criminal justice standpoint rather than as a public health
matter. Leading donors have also resisted funding needle
and syringe programs. 
t idu prevention gap: Only 11% of idus have access to
harm reduction programs.
Targeted Behavioral Interventions. Current efforts to
change sexual behavior reach only a fraction of those in
need. This is especially troubling with respect to young
people, who currently account for the overwhelming
majority of infections in the region. 
t Behavioral intervention gap: Forty percent of in-school
youth, and only 3% of out-of-school youth, are reached
by behavior change programs. Targeted behavioral
interventions reach only 4% of sex workers and their
clients, and only 9% of msm.
Diagnosis and Treatment of Sexually Transmitted
Diseases. Earlier initiation of sex among young people
and the increasing prevalence of premarital sex have
helped accelerate epidemics of stds in Eastern Europe
and Central Asia. Syphilis incidence increased 12-fold in
the Ukraine between 1990 and 1995.110 According to
unaids, between 200,000 and 400,000 cases of syphilis
are reported annually in Russia,111 with syphilis incidence
more than 37 times higher in 2000 than in 1987.112
t std treatment gap: Only 16% of people who need std
services can obtain them. 
Voluntary Counseling and Testing. To help break through
the silence and denial that surrounds the epidemic in
much of the region, it is important to expand the number
of people who know their serostatus. Unfortunately,
accessible voluntary counseling and testing services are
currently in short supply. 
t vct gap: Only 28% of people who want vct have
access.
Broad-Based hiv/aids Awareness. Governments in the
region have yet to emphasize the seriousness of the
hiv/aids threat or to underwrite broad-based awareness
campaigns. More than one-half of young people in
Ukraine, for example, have either never heard of aids
or do not accurately understand how it is transmitted,
and only 28 percent of young women in the country 
use a condom the first time they have sex.113
t Awareness gap: Only 19% of people at risk are reached
by mass media campaigns on hiv/aids.
Supportive Interventions. Rapid societal transitions in 
the region have been accompanied by a significant 
deterioration of basic public health infrastructure, which
must quickly be repaired to maximize the effectiveness 
of prevention interventions. Sustained efforts are also
needed to reduce the stigma associated with the disease
and to prevent discrimination against people living with
hiv/aids.
hiv prevention
resource gap in
eastern europe and
central asia
t Current Prevention Resources. In 2002, the Working
Group estimates that only $23 million was spent on
hiv prevention measures in the region. 
t Estimated Need. To combat the spread of hiv in
Eastern Europe and Central Asia, more than $1.2
billion in prevention spending will be required by
2005. By 2007, prevention resource needs will
increase to $1.6 billion. 
t Prevention Resource Gap: $1.18 billion additional
annual spending needed by 2005
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t Harm Reduction Programs. Just as
introduction of hiv into networks of idus
can lead rapidly to extremely high
prevalence, timely introduction of
effective prevention programs has
the capacity to yield important
dividends. In 1996, early evidence
pointed to the presence of hiv in
Keraganda Oblast, an administrative region of Kazakhstan.
Joint efforts by the government of Kazakhstan and UN
agencies, however, led to the swift establishment of a
multi-faceted prevention initiative targeting drug use,
including efforts to enhance access to sterile injection
equipment, as well as awareness campaigns targeting
idus, health professionals, the public and private sectors,
and the general public. School-based prevention programs
were initiated focusing on the hiv transmission risks of
drug use, and legal reforms were implemented to reduce
police harassment of people possessing needles and
syringes. Results of this initiative have been impressive —
the level of hiv infection among people injecting less than
a year (i.e., “recent injectors”) declined from 15 percent in
1997 to roughly five percent in 1999.114
t Youth-Oriented hiv/aids Prevention in Ukraine. 
With funding from the UN Foundation, and a partnership
with undp and unaids, the Ukraine has implemented a
nationwide program (reaching all 27 administrative
regions) to provide young people with hiv prevention 
and health education. The program trains teachers, who in
turn provide educational sessions to young people and
train youth to become peer educators. Between 2000 and
2002, the program trained more than 1,600 teachers,
substantially more than the original
target for the intervention. Although
surveys prior to initiation of the
program indicated that young people
in Ukraine had little knowledge of
hiv/aids, evaluators found that the
program significantly increased hiv-related
knowledge and substantially reduced young people’s
inaccurate impressions of injecting drug users and people
living with hiv/aids. There are currently plans to expand
the project to reach 70 percent of all young people in
Ukraine.115
t hiv Prevention Among Incarcerated Populations in
Kazakhstan. In response to evidence indicating that 
incarcerated populations are at high risk of infection in the
region, the national government’s Ministries of Internal
Affairs and of Justice initiated various policy changes to
promote effective management of the epidemic in correc-
tional facilities. Free std treatment was provided;
condoms, disinfectant and educational materials were
made available; peer educators were recruited and trained
from among the inmate population; mandatory hiv testing
was banned; and segregation of hiv-infected inmates was
ended. After the policy had been in place for one year,
inmates at four different correctional institutions were
surveyed. Results indicated significant increases among
inmates in their understanding and perception of personal
risk, understanding of the proper methods for condom use
and sterilization of injection equipment, and awareness of
opportunities for recovery from substance abuse. Corre-
sponding increases were also recorded in the knowledge
and perception of correctional staff.116
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Even with recent declines in the price of antiretroviral therapy, lifetime costs for treating a case of hiv infection in a
developing country will nevertheless be substantial. Unless the anticipated growth in new infections is prevented,
the burden on treatment and care systems in low- and middle-income countries will be unsustainable over the 
long run, even with dramatically greater global assistance for the purchase and delivery of drugs. To preserve the
hope of effective long-term treatment for the 40 million people currently living with hiv/aids, prevention efforts
must be redoubled. 
hiv prevention 
interventions are some 
of the most cost-effective
health measures available
in poor countries. A 2002
meta-analysis of 57
studies and 9 literature
reviews confirms that hiv
prevention services in
high-burden countries in
sub-Saharan Africa are
remarkably inexpensive.117
hiv prevention
a sound global investment
22
cost-effectiveness of select hiv prevention
interventions in africa
Intervention Context of Cost Per hiv Infection Prevented
Intervention in Sub-Saharan Africa (U.S. $)*
Peer Education Sex Workers in Cameroon $79–$160
(21 percent hiv prevalence)  
Diagnosis and Treatment Tanzania (four percent $271
of stds percent hiv prevalence)  
Voluntary Counseling Tanzania and Kenya,  $393–$482
and Testing (20 percent hiv prevalence) 
Rapid Testing to Screen Zimbabwe (19 percent $62
Blood Transfusions hiv prevalence) 
* Cost per infection will be higher in regions where hiv incidence is lower
Source: Creese et al, Lancet, 2002
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the caribbean and latin america
population 520,520,000
hiv prevalence 2.4%
high haiti 6.1.%
main modes of transmission heterosexual, msm, idu
status of the epidemic in 
the caribbean and latin america
t hiv Prevalence. With an adult hiv prevalence rate of 2.4 percent, the Caribbean and Latin America has the second
highest rate of infection in the world.118 Prevalence ranges from 0.1 percent in Bolivia to 6.1 percent in Haiti.119
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t Rate of Growth. Levels of hiv infection in the region
are increasing more than 10 percent annually, with an
estimated 210,000 contracting hiv in 2002.120
t Primary Modes of Transmission. The epidemic in the
Caribbean and Latin America is especially diverse,
driven by heterosexual transmission in the Caribbean,
and sex between men and injecting drug use in other
parts of the region.
t Epidemic History. The epidemic in the Caribbean and
Latin America can be traced to the late 1970s and early
1980s.121
t Key Populations for Prevention Programs. Key popula-
tions in need of prevention services include:
msm. While msm account for the single largest share 
of cumulative aids cases in the region as a whole 
(42 percent), they make up only about 10 percent of
cases in the Caribbean and Central America.122 Studies 
indicate that significant percentages of msm in the
region have sex with both men and women, suggesting
that the population may serve as an important bridge 
to the broader population.123 A seven-country study in
Central America detected hiv infection rates among
msm between 8 percent and 18 percent. Surveys of 
msm in other parts of the region have found similarly
disturbing hiv prevalence rates: 18 percent in Peru, 
15 percent in Mexico, 12 percent in Argentina, and 
11 percent in Brazil.124
idus. Injection drug use plays only marginal role 
in the epidemic’s spread in some countries, while
accounting for more than one-third of cases in some
parts of South America.125
Sex Workers. In comparison to sub-Saharan Africa 
and Asia, hiv prevalence among sex worker popula-
tions in Latin America and the Caribbean has generally
remained below five percent.126 Prevention efforts
targeting sex workers must be sustained and strength-
ened, however, as they represent both a highly vulner-
able population and one that can serve as a bridge to
other populations. 
Correctional Inmates. hiv prevalence among correc-
tional inmates in Argentina rose from 18 percent to 23
percent between 1998 and 2001. In Honduras, nearly
7 percent of all male prisoners in three urban correc-
tional settings tested hiv-positive. 
Migrant Populations. Millions of people from the
Caribbean and Latin America Caribbean work in the
U.S. and Europe, frequently returning to their native
homes (either temporarily or permanently). Studies
indicate that migrants typically engage in much higher
risk behaviors when they are away from their families
and normal surroundings.127 Especially in some rural
Mexican states, there is also evidence that some
migrant male workers transmit hiv to their wives or
girlfriends upon returning from the U.S.128
gaps in access to 
hiv prevention in 
the caribbean and
latin america
Prevention Programs for Injecting Drug Users. In countries
of South America’s Southern Cone, injection drug use is
a central factor in the spread of hiv/aids. idus comprise
40 percent of all new infections in Argentina and nearly
three in 10 new cases in Uruguay. Despite the important
contribution of injecting drug use to the spread of hiv in
the region, few idus in the region currently have access
to harm reduction programs.
t idu gap: Only 11% of idus have access to harm 
reduction programs.
Targeted Behavioral Interventions. Although transmission
among msm drives the epidemic in much of Latin
America, only one in nine msm are reached by safer 
sex programs. Other vulnerable groups are similarly
underserved.
t Behavioral intervention gap: Only 11% of msm, 4% of
out-of-school youth, 38% of in-school youth, and 6% of
sex workers and their clients have access to behavior
change programs. 
Diagnosis and Treatment of Sexually Transmitted
Diseases. Evidence is limited in the region regarding the
prevalence and incidence of key stds that might facilitate
hiv transmission. A multi-center study in Honduras
found that more than one percent of pregnant women,
nine percent of sex workers, and four percent of msm had
active syphilis.129 In Guyana, 25 percent of male patients
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and 18 percent of female patients at an std clinic in
Georgetown tested hiv-positive in 1997.130
t std treatment gap: Only 18% of people who need std
services are able to obtain them.
Voluntary Counseling and Testing. Despite the fact that
the region has one of the world’s oldest epidemics, most
people with hiv remain unaware of their serostatus.131
t vct gap: Only 29% of people who want vct have access. 
Prevention of Mother-to-Child Transmission. For the
region as a whole, mother-to-child transmission accounts
for fewer than two percent of all aids cases reported in
the region. In some countries, however — especially in
the Caribbean, where heterosexual intercourse is the
primary mode of transmission and the epidemic has
been established longer — mother-to-child transmission
represents a significant percentage of new infections,
necessitating the rapid scale-up of pmtct projects.132
t pmtct gap: Only 19% of mothers in the region (only
one in eight in the Caribbean) have access to pmtct
programs.
Broad-Based hiv/aids Awareness. unaids reports that hiv
transmission in the region is driven, in part, by “a combi-
nation of unequal socioeconomic development and high
population mobility,” leading to a growing concentration of
the epidemic among socially marginalized groups.133 Not
only are members of these populations likely to have the
least access to critical health information, but they are
often on the move in search of work, further complicating
efforts to provide essential prevention information. 
t Awareness gap: Fewer than one-third of people at risk
for hiv are reached by mass media awareness efforts. 
hiv prevention
resource gap in 
the caribbean and
latin america 
t Current Prevention Resources. In 2002, the Working
Group estimates that total prevention spending in the
region equaled approximately $195 million. 
t Estimated Need. By 2005, total annual expenditures 
of $879 million will be required to scale up proven
prevention programs. By 2007, $964 million will be
needed. 
t Prevention Resource Gap: $684 million additional
annual spending needed by 2005 
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t Integrating Prevention and Care 
in Brazil. Brazil provides the clearest
example of the potential synergy between
prevention and treatment initiatives. Brazil
combined targeted prevention programs, general
awareness campaigns, ready access to vct, universal
access to arvs and other treatments, and supportive
policies to reduce stigma and enhance the effective-
ness of prevention and care initiatives. The country
has recorded marked reductions in hiv-related
morbidity and mortality, as well as significant declines
in risk behaviors and new infections.134
t Harm Reduction Programs in South America.
A study of five harm reduction projects in Brazil found that
up to 60 percent of idus who participated in the projects
for six months were consistently using their own injection
equipment.135 Harm reduction projects may also affect
condom usage. One recent study found that
condom use by idus in Brazil increased
between 1999 and 2000 from 42 percent
to 65 percent.136
t Targeting Young People in Haiti.
The Fondation pour la Santé Reproduc-
tive et l’Education Familiale (fosref)
has established seven medical centers to
deliver comprehensive services and educa-
tion to young people at risk for hiv infection,
including contraceptive counseling, hiv/std
prevention services, hiv-related counseling,
prenatal care and support services. As of 2002,
the project had reached more than 1.5 million young
people with messages about hiv and stds, training 800
youth as hiv/std peer educators who together have visited
more than 1,300 schools nationwide.137
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Substantially increased attention is being paid to the
major disparities between rich and poor countries in
access to hiv/aids treatment. Prices of arvs have 
significantly declined, and who has certified a number 
of low-cost arvs as “essential drugs.” 
Donors, too, are showing leadership in helping to
expand treatment access. The U.S. government has
proposed to provide arv access to two million people in
14 countries over the next five years, and proposals
approved by the Global Fund to Fight aids, Tuberculosis
and Malaria will permit arv therapy for an additional
500,000 people.
Although substantial work remains to be done, there is
reason for optimism that regions that have historically
seen little or no access to standard hiv therapy will 
have the wherewithal to significantly increase treatment
access in the foreseeable future. Greater treatment
access will offer critical opportunities to strengthen
global hiv prevention efforts — by encouraging 
knowledge of serostatus, facilitating use of clinical
settings to deliver and bolster prevention programs,
reducing stigma, and potentially reducing the biological
likelihood that a single act of sexual intercourse will 
lead to hiv transmission. 
The world should seize this new opportunity to forge a
comprehensive approach to hiv/aids by integrating
prevention and treatment. Experience in industrialized
countries has shown that failure to combine prevention
with enhanced treatment access may actually lead to an
increase in risk behavior and thereby make it more 
difficult to curb the spread of the virus. (As a result,
many industrialized countries are actively working to
improve the integration of prevention and care.)
Conversely, countries like Brazil have demonstrated 
that carefully integrating prevention and care can yield
many benefits:
t Encouraging Knowledge of Serostatus. When coun-
tries have no meaningful services to offer infected
individuals, there is little incentive to learn one’s hiv
status, diminishing the potential impact of vct as an
hiv prevention measure.
t Using Clinical Settings to Deliver hiv Prevention
Services to People Living with hiv/aids. Because so
few people with hiv/aids in developing countries
attend health care settings on a regular basis, it is
difficult, if not impossible, to target prevention 
services specifically to people living with the disease 
to help them protect others from infection. Where
health care services are available, however, clinical
settings become an ideal venue for targeted preven-
tion initiatives. In particular, as treatment access
increases, health care workers will need training in
prevention counseling skills.
t Reducing Stigma. Experience in Brazil, as well as in
industrialized countries, indicates that the availability
of effective treatments helps normalize hiv/aids and
diminishes the stigma that impedes effective preven-
tion measures. 
integrating hiv prevention 
and treatment 
28
status of the epidemic in north africa 
and the middle east
t hiv Prevalence. The level of hiv infection in the adult population is lower in North Africa and the Middle East 
than in other regions — approximately 0.3 percent.
t Rate of Growth. Although the numbers are still relatively small and surveillance systems rather undeveloped,
evidence indicates three times as many people are living with hiv/aids in the region than three years ago. 
The number of people in the region living with hiv/aids increased by roughly 20 percent in 2002, bringing the 
total number to an estimated 550,000.138
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t Epidemic History. The hiv/aids epidemic in North
Africa and the Middle East began only in the late
1980s. Currently, low hiv/aids awareness and
increasing risk behavior are combining to generate the
potential for significant growth in hiv transmission. 
t Primary Modes of Transmission. Injection drug use
appears to be the principal driving force in the
epidemic; in Iran, for example, idus make up nearly
two-thirds of all reported hiv/aids cases.139
t Key Populations for Prevention Programs
idus and Their Sex Partners. Most idus in the region are
male, and nearly one third are married. Condom use
among idus is rare, however, creating potential opportu-
nities for infection to spread to their sex partners.140
Correctional Inmates. unaids reports that 10 percent
of correctional inmates in Iran inject drugs, with more
than 95 percent of such individuals sharing injection
equipment with others. Infection rates among pris-
oners rose six-fold between 1996 and 1999,141 and by
2001, one in eight drug-injecting inmates in the
country was hiv-positive. 
Other Populations. Although public health surveillance
in the region is generally weak, surveys have detected
notable infection rates among msm and among sex
workers and their clients.142
gaps in access to 
hiv prevention in
north africa and 
the middle east
Harm Reduction Programs for Injecting Drug Users.
Injection drug use appears to be a growing problem in
North Africa and the Middle East, increasing the region’s
vulnerability to a significant increase in hiv/aids.
t idu gap: Access to harm reduction programs is almost
non-existent in the region.
Targeted Behavioral Interventions. The potential for
growth in infection rates is underscored by the scarcity 
of behavior change programs for highly vulnerable 
populations.
t Behavioral intervention gap: Only 5% of sex workers
and their clients, 10% of msm, 2% of out-of-school
youth, and 27% of in-school youth have access to
behavioral interventions. 
Diagnosis and Treatment of Sexually Transmitted
Diseases. According to unaids, stds in Iran significantly
increased between 1995 and 1998.143 In Morocco, a
country of approximately 30 million people, nearly
350,000 cases of stds were reported in 2001.144
t std treatment gap: Only 16% of people who need std
services are able to obtain them.
Voluntary Counseling and Testing. According to who and
unaids, North Africa and the Middle East is the most
underserved region with respect to vct.
t vct gap: Only 6% of people who want vct have access.
Broad-Based hiv/aids Awareness. As a result of the 
relative newness of the epidemic and the lack of a 
political response, few people in the region perceive
themselves to be at risk for hiv infection. 
t Awareness gap: Fewer than one-fifth of people at risk
have access to hiv/aids information through the
media.
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t An Integrated Prevention 
Approach in Morocco. Beginning 
in 1996, amsed, a Moroccan
ngo, established a program to
prevent hiv and std transmission
that has grown to involve more than 30
community organizations. Building on initial efforts
to increase awareness, access to condoms, and link-
ages to std prevention and treatment services among
female sex workers and msm, the program has since collab-
orated with the Moroccan government to integrate hiv,
sexual health, and gender awareness into the government’s
literacy programs. Based on the success of these 30
community-based pilot projects, Morocco’s country coordi-
nation mechanism for the Global Fund to Fight aids, Tuber-
culosis and Malaria has agreed to seek substantial new
funding to bring these programs to scale.145
t Behavioral Interventions for idus in Iran. In Kermanshah,
a mountainous province bordering on Iraq, the first case of
hiv infection was detected in 1995, but numbers grew,
reaching 1,228 in 2001. With most of these cases stemming
from needle sharing during injecting drug use, the govern-
ment implemented a multi-faceted program to promote
behavior change to reduce new infections among the
region’s drug-using population. The behavioral model
implemented in Kermanshah focuses on the related
epidemics of hiv, stds and drug dependence. The program
seeks to create a policy environment that
is conducive to hiv prevention activities
among idus, and actively cultivates and
supports networks of people living with
hiv/aids. Evaluators report significant
behavior changes among idus served
by the program, including reduc-
tions in drug use, needle sharing and
unsafe sex. Based on the success of Kermanshah’s
initiative, two similar behavioral projects have recently been
initiated in Teheran.146
t Promoting hiv Prevention Among msm in the Maghreb.
alcs, a Casablanca-based ngo, has pioneered efforts to
establish peer education and health service programs for
msm, including men who engage in sex work, as well as
men living with hiv/aids. Working with the International
hiv/aids Alliance, alcs has collaborated with other ngos
in the region to replicate these approaches in Algeria,
Mauritania, Tunisia, and other countries of the Maghreb
region. After early experience with these programs demon-
strated that stigma within ngos can impede effective
prevention programming for msm, a new programmatic
strategy was adopted to focus on community organizing 
of msm and people living with hiv/aids. These efforts are
supporting communities in the development of peer
outreach, self-help collectives, and partnerships with 
other ngos.147
hiv prevention
resource gap in
north africa and 
the middle east
t Current Prevention Resources. The Working Group
estimates that, in 2002, $23 million was spent on hiv
prevention activities in the region. 
t Estimated Need. To respond to the growing epidemic
in North Africa and the Middle East, annual expendi-
tures of $192 million will be required for hiv preven-
tion activities by 2005. Nearly $210 million in annual
spending will be needed in the region by 2007.
Mounting the kind of prevention response capable of
preventing a significant outbreak of hiv/aids in the
region will require a 10-fold increase in spending. 
t Prevention Resource Gap: $169 million additional
annual spending needed by 2005
30
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While 95 percent of all infections occur in low- and
middle-income countries, the fight against the epidemic
is not over in wealthier countries. Prevention efforts in
North America, Western Europe, and Australia must also
be strengthened and reinvigorated in order to prevent
another wave of infections. 
An increasing body of evidence indicates that people in
developed countries, especially msm, have increased risk
behaviors in recent years.148 In several cities in North
America and Europe, hiv infection rates among msm
appear to be on the rise, and African-American msm
have infection rates that rival those seen in parts of
Africa.149
Studies in industrialized countries strongly suggest that
people who feel most optimistic about hiv therapies are
most likely to engage in unprotected sex.150 In addition,
substantial percentages — often one-half or more — 
of msm involved in recent syphilis outbreaks in several
urban areas in the U.S. are hiv-positive, underscoring
the importance of effective prevention programs for
people already living with hiv.151
To strengthen prevention efforts in industrialized 
countries, the following actions are needed:
t Prevention Programs for Positives. Many wealthier
countries are now recognizing the importance of
specifically targeting people living with hiv/aids with
appropriate prevention interventions. In particular,
enhanced efforts are needed to use clinical settings to
deliver and reinforce hiv prevention interventions.
t Identifying Prevention Models for the Treatment Era.
Although overwhelming evidence demonstrates the
effectiveness of available prevention strategies,
existing approaches were designed at an earlier stage
of the epidemic, when hiv infection invariably meant
rapid disability and death. With significantly fewer
people now dying of the disease in industrialized
countries, enhanced research efforts are needed to
identify new strategies and program models that 
effectively communicate the continued seriousness 
of hiv/aids in areas where effective treatments are
widely available.
t Strengthened Prevention Efforts Targeting msm.
The earliest prevention success in the epidemic
occurred among msm in industrialized countries, who
dramatically lowered infection rates by altering their
sexual practices. With the epidemic now in its third
decade, greater prevention efforts are especially
needed for young msm, who never experienced the
height of the epidemic, and for msm from racial and
ethnic minorities, who are often at substantially
greater risk of infection. In addition, research is
needed to identify effective strategies to renew and
reinvigorate prevention efforts to older msm who may
be experiencing “prevention burnout” due to two
decades of exposure to risk reduction messages. 
t Voluntary Counseling and Testing. Nearly 20 years
after development of the hiv antibody test, lack of
knowledge of serostatus continues to impede 
effective prevention and treatment efforts in wealthier
countries. In the U.S., for example, officials estimate
that 19 to 33 percent of people infected with the virus
are unaware of their hiv status.152
t Enhanced Prevention Funding. In recent years,
funding for hiv prevention activities has flattened, or
even declined, in many industrialized countries. Rein-
vigorating prevention efforts in these countries will
require new resources. In the U.S. alone, it is esti-
mated that an additional $300 million in annual
prevention spending is needed to mount an effective,
comprehensive prevention effort.153
industrialized countries
preventing a resurgence of 
hiv transmission
SOURCES OF FUNDING FOR HIV/AIDS PROGRAMS IN 2002 (U.S. $)
Total Spending on Estimated Estimated
Funding Source hiv/aids Spending on Spending on hiv
Programs Care and Support Prevention
Developing Countries $1.7 billion $918 million $782 million 
Bilateral Donors $1.3 billion $520 million $780 million 
Foundations/ ngos $200 million $40 million $160 million 
United Nations System $150 million $50 million $100 million 
World Bank $95 million $31 million $64 million 
TOTAL $3.5 billion $1.6 billion $1.9 billion
Source: unaids; Working Group analysis
n every region, substantial gaps exist in access to
essential hiv prevention interventions. Closing the
hiv prevention access gap — worldwide and in
specific regions — will require significant new
outlays from both developed and developing countries. 
In short, a major effort to mobilize unprecedented
resources for hiv prevention programs, coupled with 
the scale-up of treatment programs, will be needed to
reverse the global epidemic.
Such sums, however, must be placed in perspective.
For relatively modest amounts, gaps in access to key inter-
ventions could be rapidly narrowed or even eliminated.
t For less than one dollar per year for every American
($252 million), the global community could ensure
effective worldwide access to voluntary counseling and
testing.
t Optimal worldwide access to harm reduction interven-
tions would require annual expenditures of only $46
million, less than one euro per year per person in France. 
t One euro per year for every German ($82 million) could
ensure that all students in developing countries receive
school-based hiv education and prevention programs. 
Overall, according to an expert panel of economists
convened by unaids, prevention resource needs for 
low- and middle-income countries will amount to 
approximately $5.7 billion in 2005, while spending on
antiretrovirals and treatment for opportunistic infections 
should increase to $4.5 billion. 
The challenge facing the global community is to imme-
diately marshal sufficient resources to ensure rapid scale-
up of life-saving prevention strategies. With sufficient
resources, existing strategies can effectively reverse the
epidemic by decade’s end. In the absence of such global
commitment, the epidemic will continue its expansion. 
current spending 
on hiv prevention
unaids estimates that resources available from all
sources for hiv/aids programming of any kind (i.e.,
prevention, care, support and treatment) at the country
level in 2002 amounted to $3.5 billion. 
In tracking resources, unaids distinguishes between
funds that have been committed by donors in a particular
year and resources that are actually available for use in
any given year at country level, tracking only the latter.
unaids estimates also omit pledges for future spending
(for example, to the Global Fund to Fight aids, Tubercu-
losis, and Malaria), as the analysis is limited to resources
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actually available in a given year for prevention programs.
In addition, unaids estimates seek to track only spending
that can be traced to a package of standard interventions,
excluding such items as public health surveillance or
infrastructure capacity development.* 
Using initial unaids figures for overall hiv/aids
spending of $3.5 billion in 2002, the Working Group
undertook subsequent investigation to obtain estimates
of spending specifically for standard hiv prevention
measures. The absence of reliable tracking mechanisms
for spending made it impossible for the Working Group
to identify current spending with a high degree of 
precision. Yet based on the best available information, 
the Working Group estimates that a total of $1.9 billion
was spent in 2002 on HIV prevention measures — 
54% of total aids spending. A total of $1.6 billion was
directed to care and support programs for those infected
and affected by hiv/aids.‡
Developing Country Sources
Developing countries themselves account for the single
largest share of spending on hiv/aids programs in low-
and middle-income countries, contributing an estimated
$1.7 billion in 2002 for prevention, treatment, care 
and support programs. Financial support for hiv/aids
interventions at country level are attributable to two
sources of roughly equal size — outlays by the private
sector, primarily from affected households, and 
expenditures by domestic governments.
Differentiation between prevention and other forms
of hiv/aids spending from domestic sources is 
challenging due to lack of reliable data. Given the limited
or frequently non-existent access to basic health care,
combined with the inevitable pressures on affected
households and domestic governments to prioritize 
care for people who are seriously ill, it is reasonable to
assume that most domestic hiv/aids spending focuses
on treatment, care and support over preventive measures,
although in middle-income countries private outlays for
condom purchase, blood screening and other prevention
items are likely to be considerable.
According to unaids, Latin America has historically
accounted for the vast majority of domestic spending on
hiv/aids. Recently, however, other middle-income coun-
tries, most notably South Africa and Thailand, have signif-
icantly increased their spending on hiv/aids programs.
In 2002, for example, unaids estimates that South Africa
allocated $100 million toward hiv prevention measures. 
Latin America and the Caribbean is the only region for
which it is possible to make a reasonable estimate of the
breakdown between prevention and non-prevention
spending. According to a five-country study of hiv/aids
spending patterns in Latin America, 46 percent of all
domestic spending (public and private) on hiv/aids in the
region focuses on hiv prevention interventions. In the
absence of other reliable data sources, the Working Group
has estimated that domestic government and household
spending in other countries follows a similar pattern,
leading to an overall estimate of $782 million for devel-
oping country spending on hiv prevention in 2002.
Bilateral Programs Administered by Donor Countries
In 2002, unaids projects that bilateral donors
contributed more than $1.3 billion in funding for all
hiv/aids interventions in developing countries, making
these donors the second largest source of financial
support for hiv/aids programs. Roughly two-thirds of
bilateral hiv/aids spending in 2002 derived from two
donors — the U.S. ($514 million) and the United
Kingdom ($300 million). 
Categorizing hiv/aids spending is challenging, as
most donors do not report spending by program category
(e.g., prevention, care, treatment, support, etc.). Although
prevention historically accounted for the large majority of
usaid spending on hiv/aids, the share of prevention
spending has fallen in recent years with the scale-up of
care and support services. Prevention interventions,
including prevention of mother-to-child transmission,
currently account for approximately 57 percent of the
usaid hiv/aids portfolio.154
The U.K. Department for International Development
approaches its hiv/aids work at country-level in a cross-
cutting, multisectoral manner that makes it difficult to
establish a percentage specifically for hiv prevention. 
As dfid reports that the bulk of its programming focuses
on prevention, the Working Group has assumed that 
two-thirds of dfid’s hiv/aids spending — 67 percent —
can be categorized as prevention. 
Using the weighted average of the share of prevention
spending in the U.S. and U.K. hiv/aids portfolios (60
percent), the Working Group has applied this percentage
* In the case of hiv prevention, interventions tracked by unaids include (1) in-
school prevention programs for youth, (2) prevention interventions for out-of-school
youth, (3) targeted interventions for sex workers and their clients, (4) social mar-
keting, (5) condom provision, (6) enhanced std control activities, (7) vct, (8) work-
place prevention programs, (9) blood safety interventions, (10) pmtct, (11) mass
media awareness interventions, (12) harm reduction programs, (13) targeted inter-
ventions for msm, (14) post-exposure prophylaxis, (15) safe injections, (16) universal
precautions in health care settings, and (17) policy, administration and research.    
‡ In the case of care and support, interventions tracked by unaids include (1)
palliative care, (2) hiv testing, (3) treatment for opportunistic infections, (4)
prophylaxis for opportunistic infections, (5) arv therapy, and (6) orphan support,
including community support, orphanages, and school fees.
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to resources available from other bilateral donors. 
Altogether, the Working Group estimates $780 million 
in bilateral funding for hiv prevention interventions at
country level. As the chart above demonstrates, however,
the level of support for hiv prevention among leading
donor countries varies considerably.
While bilateral support for prevention clearly must
increase, these data also highlight the need for increased
spending for care and support.
Foundations and ngos
unaids estimates that foundations and ngos contributed
$200 million in financial support for hiv/aids programs
in developing countries in 2002. At present, no database
exists to permit differentiation of prevention from other
forms of spending by foundations and ngos. 
The Working Group obtained information regarding
2002 spending on programs in developing countries
from four leading foundations — the Bill & Melinda
Gates Foundation, Henry J. Kaiser Family Foundation,
Rockefeller Foundation, and United Nations Foundation.
Prevention research funding was excluded from this
analysis. With the exception of Rockefeller Foundation,
which in 2002 prioritized grants for care and treatment,
most spending in 2002 by these foundations focused on
hiv prevention. Altogether, these four foundations
provided approximately $100 million in funding for hiv
prevention programs in developing countries in 2002.
On the basis of its analysis of spending by these leading
foundations, the Working Group estimates that 80
percent, or $160 million, of amounts spent by founda-
tions and ngos on programmatic interventions in 2002
were allocated to hiv prevention. 
United Nations Agencies
unaids estimates that the UN system (excluding the
World Bank) provided $150 million in financial support
for hiv/aids programs in developing countries in 2002.
The Unified Budget and Workplan of unaids — which
combines and harmonizes activities of the unaids Secre-
tariat and eight unaids Cosponsor agencies — supports
global and regional activities of the joint unaids program,
as well as unaids support for governments to develop and
implement national multisectoral hiv/aids strategies.
In addition to regional and global activities and
national strategic planning through unaids, various UN
agencies also support national efforts to mount hiv/aids
programs. Prominent among these UN sources of
funding for national efforts are undp, unesco, unfpa,
unicef, the World Health Organization, and the Depart-
ment of Peacekeeping Operations of the UN Secretariat. 
No methodology currently exists to determine with
precision the magnitude of UN system resources for
country-level prevention programs. An analysis of budget
documents for country-level activities of unaids Cospon-
sors, however, indicates that country-level assistance
provided by these key UN agencies is weighted strongly
toward hiv prevention, including condom promotion
and distribution, prevention of mother-to-child transmis-
sion, expansion of school-based hiv prevention
programs, and targeted prevention programs for vulner-
able populations. Accordingly, the Working Group esti-
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ESTIMATED SPENDING IN 2002 BY SELECT DONOR COUNTRIES
FOR GLOBAL AIDS PROGRAMS
Total for hiv/aids Total for Global Share of gdp for Share of gdp for 
Programs hiv Prevention hiv/aids Global hiv
Country (U.S. $ millions) (U.S. $ millions) Programs* Prevention*
United Kingdom 300 200 0.021% 0.014% 
Norway 35 21 0.021% 0.013%  
Netherlands 55 33 0.014% 0.009%  
Canada 39 23 0.006% 0.003%  
United States 514 293 0.005% 0.003%  
Sweden 11 6‡ 0.005% 0.003%  
Germany 55 33 0.003% 0.002%  
Japan 100 60 0.002% 0.001%  
France 25 15 0.002% 0.001%  
* Figures for national gdp derive from the World Bank’s World Development Indicators 2002. | ‡ Estimated spending in 2001; 2002 figures unavailable. | Source: dﬁd, Paul Delay, Working Group analysis
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mates that two-thirds of the $150 million provided by 
UN agencies for hiv/aids programs in 2002 (or $100
million) may be classified as hiv prevention. 
World Bank
According to unaids, the World Bank provides $95
million in direct support for hiv/aids programming in
2002, calculated as a combination of outright grants to
countries and the financial value of the concessionary
portion of World Bank hiv/aids loans. An analysis of the
World Bank portfolio of hiv/aids programming indicates
that roughly two-thirds of the Bank’s hiv/aids assistance
to countries is for hiv prevention, although the degree to
which such disease control spending finances actual inter-
ventions, as opposed to surveillance and capacity-building,
is unclear. In addition, the World Bank has categorized
several programs as hiv prevention even though they
support both hiv and tb control activities. Using the two-
thirds assumption, the Working Group estimates that the
Bank contributed nearly $64 million for hiv prevention
programs at country level in 2002.
resources
needed to
mount an
effective
response
Recent work by an expert panel of
economists convened by unaids
indicates that resource needs for
hiv prevention in low- and middle-
income countries will amount to
approximately $5.7 billion annually
in 2005. By 2007, $6.6 billion in
annual prevention spending will
be required to address global needs, representing 39
percent of total hiv/aids resources needed in 2007.*
These estimates must be understood as minimums, as
they do not include spending on capacity building,
supportive interventions, or reasonable administrative
expenses associated with any efficient form of external
assistance.
Reaching these spending targets is a matter of over-
riding global importance. According to unaids, who and
leading epidemiologists and health care economists, such a
comprehensive prevention effort would prevent 29 million
of the 45 million new infections projected in this decade.155
In 2007, sub-Saharan Africa and Eastern Europe will
each require between 20 and 25 percent of projected
resources for hiv prevention; Asia and the Pacific will
require 35 to 40 percent; Latin America and the
Caribbean approximately 15 percent; and North Africa
and the Middle East roughly three percent. 
The urgent prevention spending increases needed
must occur in the context of sharp, sustained increases in
all forms of hiv/aids spending. unaids estimates that
minimum financing needed to bring to scale treatment
programs for opportunistic infections will amount to
$2.6 billion by 2005. Given the rapidly growing global
population of people for whom antiretroviral therapies
are clinically indicated, annual outlays for the purchase,
delivery and monitoring of arvs should grow to $1.9
billion by 2005 and to $3.75 billion by 2007. According to
unaids, programs to support aids orphans and others
made vulnerable by the epidemic will require at least $1
billion annually. 
There are important indications that spending on 
hiv prevention and other hiv/aids programs is on the
rise, although the rate of increase must accelerate further
still if the 2005 and 2007 funding targets are to be met. 
The Global Fund to Fight aids,
Tuberculosis and Malaria, which only
became operational in 2002, expects to
deliver several hundred million dollars
for programmatic scale-up in affected
countries in 2003. As of March 2003,
the Global Fund had collected $3.4
billion in financial pledges.
In January 2003, U.S. President
George W. Bush announced a
proposed initiative that would triple
U.S. financial support for hiv/aids
programs, generating $10 billion in
new hiv/aids spending over the next
five years. The initiative would
commit substantial new funds to
scaling up both prevention and treatment programs in 
14 countries in Africa and the Caribbean. 
* The decline in the prevention share of overall hiv/aids spending from current
patterns (54 percent) to the proper prevention share in 2007 (39 percent) as part of
a comprehensive global approach to hiv/aids stems from at least two factors.
First, global coverage for arvs (4 percent) is even lower than coverage rates
reported for key prevention interventions, requiring an even steeper scale-up in
future years for treatment. Second, because long-term arv therapy is more costly
than most prevention interventions, the balance between prevention and
care/treatment resources will inevitably change as global scale-up occurs. In any
event, achieving spending targets for prevention in 2007 will nevertheless require
a nearly four-fold increase in available resources, underscoring the global urgency
of rapid scale-up of both prevention and treatment programs.  
0
1
2
3
4
5
6
7
8
2002
Prevention
Spending
$1.9
Amount
Needed
in 2007
$6.6
Amount
Needed
in 2005
$5.7
bi
ll
io
n
s 
(u
.s
. $
)
Source: unaids; Working Group analysis
Global hiv Prevention Resource Needs
Although existing prevention strategies are highly 
effective, the global peril posed by hiv/aids demands
that urgent efforts be undertaken to devise new strategies
to for the combination prevention portfolio. Unfortu-
nately, only 10 percent of medical research spending is
devoted to diseases that primarily affect poor countries
and cause 90 percent of the global health burden.156
Moreover, prevention research has historically garnered 
a relatively small share of research spending. 
No comprehensive database currently exists to track
spending on hiv prevention research. The U.S. National
Institutes of Health, the largest single source of funding
for hiv-related research, provided $977 million in support
for hiv prevention research (domestic and international)
in its 2002 fiscal year, including more than $329 million
for hiv vaccine research. In 2001, the U.S. Centers for
Disease Control spent approximately $79 million for hiv
prevention research, including nearly $14 million on
research outside the U.S. The Bill & Melinda Gates Foun-
dation disbursed $139 million in 2002 to support hiv
prevention research. Other governments and multilateral
agencies also support behavioral, intervention and opera-
tional research relevant to global hiv prevention efforts.
Current sums, however, are clearly inadequate to
meet the challenge posed by hiv/aids. The global
community must devote substantial new resources to
the search for new prevention tools to add to the
“combination prevention” inventory. 
t Vaccines. Twenty years after research into a preven-
tive vaccine began, only one candidate vaccine has been
tested for efficacy and numerous promising avenues for
hiv vaccination are not being pursued due to lack of
public and private support.157 The International aids
Vaccine Initiative estimates that an increase of $1 billion
in public and private sector support for vaccine research
will be needed to pursue potentially promising research
avenues that are currently not being addressed.158
Public sector policies are also urgently needed to
provide pharmaceutical and biotech companies with
financial incentives to increase their involvement in hiv
vaccine research. 
t Microbicides. A safe and effective microbicide would
provide protection against hiv when a condom is not
used — a potential benefit of particular importance to
women who may not be able to negotiate condom use
with their partners. Lack of public and private sector
support for microbicide research has made it difficult to
move promising candidates through the r&d pipeline,
although six products are ready to enter large scale effec-
tiveness trials soon.159 Experts in the microbicide field
estimate that at least $1 billion in additional spending is
needed to accelerate r&d efforts.160
t Antiretroviral Therapies. As plasma viral load has been
closely associated with likelihood of transmission, studies
are beginning to examine whether widespread arv
therapy will reduce rates of new infections. Additional
research is also ongoing to improve arv regimens for the
prevention of mother-to-child transmission, and to
examine whether pre- and/or post-exposure administra-
tion of arvs can help prevent transmission. 
t Behavioral Intervention Research. Although over-
whelming data demonstrate the effectiveness of existing
interventions in reducing the frequency of behaviors
that facilitate hiv transmission, additional research is
needed to identify effective strategies to reach marginal-
ized populations (such as injecting drug users, men
who have sex with men, and sex workers) in diverse
cultural settings. 
t Female Barrier Methods. Another relatively new area of
research focuses on whether female diaphragms or other
alternative female-controlled barrier methods might offer
protection against hiv transmission.
t Circumcision. Numerous studies have found that
men who were circumcised as infants are significantly
less likely to contract hiv.161 No study, however, has
examined whether adult circumcision would be effective
in reducing the risk of transmission. Three studies in
Africa (Kenya, South Africa, and Uganda) are being 
initiated to examine this question. 
t std Control. Although std prevention, diagnosis and
treatment are universally recognized as central compo-
nents of an effective hiv prevention strategy, compli-
cated methodological questions remain about which
stds should be targeted and which std control strate-
gies should be prioritized to reduce the risk of hiv
transmission.162 Trials have been planned to look into
such questions, but additional clinical and operational
research will be needed. 
accelerating prevention research
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o mount the response needed to reverse the
global epidemic, the Working Group makes 
the following recommendations and urges their
rapid implementation:
Global spending on hiv prevention activities from all
sources should increase three-fold by 2005 to $5.7 billion,
and to $6.6 billion by 2007.
t Donor nations, which currently contribute less than
one-half of all spending on hiv/aids programs in
developing countries, should substantially increase
their assistance to low- and middle-income countries
by contributing a minimum of 0.02 percent of gdp to
hiv prevention activities by 2005. The Working Group
estimates that his would yield an additional $5 billion
in annual resources for hiv prevention measures, yet
the relative cost to industrialized nations would be
marginal.*
t This spending increase for prevention should occur 
in the context of a dramatic, comprehensive scaling-up
of support for all hiv/aids efforts, including care, 
treatment and support programs. Annual spending on
treatment of opportunistic infections should increase
to $2.6 billion by 2005, while annual outlays for 
scale-up of antiretroviral treatment should grow to 
$1.9 billion by 2005 and to $3.75 billion by 2007.
Programs to support aids orphans will require at 
least $1 billion annually. 
t Because prevention services will benefit from a range 
of strong, flexible funding sources, significant new
funding from donor nations, foundations and the
corporate sector should be directed toward the Global
Fund to Fight aids, tb and Malaria. Donors should
contribute at least $2 billion to the Global Fund in 2003
and at least $4.6 billion in 2004 to permit the Fund to
help countries scale up hiv prevention and treatment,
as well as tuberculosis and malaria programs. 
t Current debt relief mechanisms should be aggressively
used (by both debtor and creditor countries) and 
additional relief should be approved to free domestic
resources to underwrite hiv prevention activities. 
t With who advising that developing countries
contribute a third of the amounts required to meet
funding targets in 2005 and beyond, affected countries
should prioritize hiv prevention in their budget 
allocations. Increased support by international donors
is needed to reduce or eliminate the need for hiv-
related household outlays in least developed countries. 
t Given the difficulties in tracking hiv prevention
spending discovered in this analysis, spending on hiv
prevention and other hiv/aids spending should be
reported and tracked much more carefully to ensure
transparency, to allocate funds most strategically, and
to facilitate analysis of spending trends to ensure that
spending meets global needs.
Because prevention efforts currently fall short of what is
needed in every region of the developing world, preven-
tion scale-up must be a central priority in each region. 
t By 2005, annual spending on hiv prevention activities in
sub-Saharan Africa should increase from $927 million to
$1.5 billion. Particular emphasis should be placed on
prevention programs targeted to youth, who represent
the future of the epidemic in hardest-hit Africa.
t By 2005, annual spending on hiv prevention activities
in the Caribbean and Latin America should increase
from $210 million to $879 million. 
RECOMMENDATIONS
* unaids/who advise that affected countries themselves should cover one-third of
the cost of the response to hiv/aids. This would imply that the prevention share
in 2005 for donor countries and other sources would be $3.8 billion. The
Working Group recommends that donor nations contribute $5 billion in order to
help cover other essential costs that are not included in the financing of interven-
tions themselves, such as infrastructure support, human capacity-building, and
supportive interventions.
t By 2005, annual spending on hiv prevention activities
in Asia must increase from 2002 levels by $1.4 billion.
To prevent hiv from rapidly spreading into the broader
population, programs in Asia should prioritize high-
risk populations.
t By 2005, an annual increase over current spending
levels of $1.17 billion is required to scale up combina-
tion prevention in Eastern Europe and the countries 
of the former Soviet Union.
t Political, religious, business and other leaders must
actively embrace the fight against hiv/aids in all
regions, but especially in Asia and Eastern Europe,
where fast-growing epidemics are now emerging.
Leaders must speak publicly about the urgent need 
for prevention scale-up, and support a sound, 
science-based response to the epidemic. In particular,
leadership is needed to assist countries in overcoming
resistance to non-coercive prevention programs
addressing the needs of idus. Due to the relative
newness of the hiv/aids threat in these regions,
substantial investment is immediately needed in 
both broad-based and targeted hiv/aids awareness
campaigns.
In the immediate future, prevention efforts should aggres-
sively focus on bringing to scale especially cost-effective,
high-impact interventions.
t vct: Donor nations, affected countries, multilateral
institutions, foundations and ngos should collaborate
in the rapid scale-up of accessible vct programs,
making optimal use of rapid testing technologies.
t Harm reduction for IDUs: Scale-up of harm reduction
programs should be urgently prioritized, as they have
been proven to be highly effective in curbing the
spread of hiv/aids in areas where injecting drug use 
is common. Globally, such a scale-up would cost only
$46 million annually, yet the approach could help
prevent the projected explosion of cases in Russia,
China, India, Eastern Europe and Central Asia.
t std control: Scale-up of std control programs is 
especially critical in Asia, where spiraling std rates are
accelerating the spread of hiv/aids into the broader
population.
t pmtct: Global efforts should be strengthened and
accelerated to bring to scale programs to prevent
mother-to-child transmission. By strengthening the
prenatal care infrastructure of low-income countries,
pmtct scale-up would have additional, long-term 
benefits apart from hiv prevention.
t Condom supply: Donor nations, foundations and multi-
lateral agencies should collaborate in the development
and rapid implementation of an emergency plan to
ensure an adequate supply of condoms to meet the
demands created by scaled-up prevention efforts. 
Additional spending of almost $200 million annually is
required to ensure an adequate global condom supply. 
As both prevention and treatment programs are brought
to scale, these initiatives should be carefully integrated to
create a single continuum of services.
t As vct programs are scaled up, referral and linkage
mechanisms must be established and monitored to
ensure that individuals who test hiv-positive are
rapidly integrated into care programs.
t Health care workers in hiv/aids care settings in low-
and middle-income countries should receive compre-
hensive and periodically reinforced training in hiv
prevention counseling. Clinical settings should 
maintain up-to-date lists of community prevention
resources and make referrals, where needed.
t Prevention programs specifically designed for people
living with hiv/aids should be provided in settings
where such individuals receive medical and support
services.
t As treatment programs are scaled up, health care
workers should receive training in standard infection
control procedures. Donors should provide 
funding for state-of-the-art technologies to prevent
blood exposures.
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In addition to funding prevention interventions them-
selves, donors should, in collaboration with multilateral
agencies, provide extensive additional support to build
long-term human capacity and infrastructure.
t Substantial new resources, over and above amounts
needed for programs themselves, should be allocated for
the building of long-term human and physical capacity
to mount hiv prevention efforts. Research should 
be urgently initiated to identify the level of financial
resources required to underwrite needed capacity
building to support long-term hiv prevention efforts. 
t Substantial new resources should specifically be 
allocated annually for training local personnel, trans-
ferring key prevention technologies, and supporting
international mechanisms to share prevention
expertise across national borders. 
t Planning for human capacity development in devel-
oping countries should take account of the fact that 
the epidemic itself will significantly diminish human
capacity at country-level in future years, underscoring
the importance of a long-term commitment by donors
to capacity-building programs.
Development assistance and policy reforms should
address the social and economic conditions that increase
vulnerability to, and facilitate the rapid spread of,
hiv/aids.
t Donor nations should ensure that official development
assistance equals at least 0.7 percent of gdp.
t Donor countries should reduce trade barriers that
impede economic development of poor countries 
and take active steps to expand trade with developing
countries.
t Available debt relief mechanisms should be effectively
used, and additional relief mechanisms should be
explored, to maximize the amount of domestic
resources available to support hiv/aids programs 
and other health initiatives.
t Recognition of the role of gender inequality in perpetu-
ating hiv/aids and poverty should be integrated into
all international development efforts. In particular,
donor nations should provide substantially increased
support for women’s microfinance programs, girls’
education initiatives, and other programs that
empower women and girls. 
Research into new prevention strategies and technologies
should be strengthened and accelerated.
t Public sector funding for research and development
should increase by $1 billion for hiv/aids vaccines and
by $1 billion for microbicides.
t Key research agencies and multilateral institutions
should meet annually to assess the state of prevention
science research and to identify gaps that should be
addressed. 
t Key multilateral institutions — such as who and
unaids — should be prepared to provide swift guidance
on implementation of new prevention strategies as
they emerge.
t National hiv/aids strategies should anticipate and 
plan for the rapid introduction of new prevention tools
as they emerge.
Substantial and sustained efforts by all donors should
focus on improving data collection regarding the 
magnitude and nature of hiv/aids spending in low- 
and middle-income countries.
t Bilateral donors, multilateral donors, ngos and founda-
tions should report annually to a single data collection
mechanism regarding the magnitude of funds avail-
able for hiv/aids programming at country level, the
precise types of programs supported by such funding,
and the countries, districts or urban areas targeted by
such programs. 
t Donors should increase their support to unaids to
enhance its capacity to track and report on the flow of
hiv/aids resources in developing countries.
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